Eric J. Arts - Publications

Case Western Reserve University, Cleveland Heights, OH, United States 

116 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Ndashimye E, Avino M, Olabode AS, Poon AFY, Gibson RM, Li Y, Meadows A, Tan C, Reyes PS, Kityo CM, Kyeyune F, Nankya I, Quiñones-Mateu ME, Arts EJ. Accumulation of integrase strand transfer inhibitor resistance mutations confers high-level resistance to dolutegravir in non-B subtype HIV-1 strains from patients failing raltegravir in Uganda. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. PMID 32853364 DOI: 10.1093/jac/dkaa355  0.32
2019 Poon AFY, Ndashimye E, Avino M, Gibson R, Kityo C, Kyeyune F, Nankya I, Quiñones-Mateu ME, Arts EJ. First-line HIV treatment failures in non-B subtypes and recombinants: a cross-sectional analysis of multiple populations in Uganda. Aids Research and Therapy. 16: 3. PMID 30670037 DOI: 10.1186/s12981-019-0218-2  0.32
2018 Klein K, Nickel G, Nankya I, Kyeyune F, Demers K, Ndashimye E, Kwok C, Chen PL, Rwambuya S, Poon A, Munjoma M, Chipato T, Byamugisha J, Mugyenyi P, Salata RA, ... ... Arts EJ, et al. Higher sequence diversity in the vaginal tract than in blood at early HIV-1 infection. Plos Pathogens. 14: e1006754. PMID 29346424 DOI: 10.1371/journal.ppat.1006754  0.36
2017 Gibson RM, Nickel G, Crawford M, Kyeyune F, Venner C, Nankya I, Nabulime E, Ndashimye E, Poon AFY, Salata RA, Kityo C, Mugyenyi P, Quiñones-Mateu ME, Arts EJ. Sensitive detection of HIV-1 resistance to Zidovudine and impact on treatment outcomes in low- to middle-income countries. Infectious Diseases of Poverty. 6: 163. PMID 29202874 DOI: 10.1186/s40249-017-0377-0  0.32
2016 Krebs KC, Tian M, Asmal M, Ling B, Nelson K, Henry K, Gibson R, Li Y, Han W, Shattock RJ, Veazey RS, Letvin N, Arts EJ, Gao Y. Infection of rhesus macaques with a pool of simian immunodeficiency virus with the envelope genes from acute HIV-1 infections. Aids Research and Therapy. 13: 41. PMID 27906032 DOI: 10.1186/s12981-016-0125-8  0.48
2016 Venner CM, Nankya I, Kyeyune F, Demers K, Kwok C, Chen PL, Rwambuya S, Munjoma M, Chipato T, Byamugisha J, Van Der Pol B, Mugyenyi P, Salata RA, Morrison CS, Arts EJ. Infecting HIV-1 Subtype Predicts Disease Progression in Women of Sub-Saharan Africa. Ebiomedicine. PMID 27751765 DOI: 10.1016/j.ebiom.2016.10.014  0.36
2016 Asmal M, Lane S, Tian M, Nickel G, Venner C, Dirk B, Dikeakos J, Luedemann C, Mach L, Balachandran H, Buzby A, Rao S, Letvin N, Gao Y, Arts EJ. Pathogenic infection of Rhesus macaques by an evolving SIV-HIV derived from CCR5-using envelope genes of acute HIV-1 infections. Virology. 499: 298-312. PMID 27723488 DOI: 10.1016/j.virol.2016.09.021  0.96
2016 Kyeyune F, Gibson RM, Nankya I, Venner C, Metha S, Akao J, Ndashimye E, Kityo CM, Salata RA, Mugyenyi P, Arts EJ, Quiñones-Mateu ME. Low Frequency Drug Resistance in HIV-infected Ugandans on Antiretroviral Treatment is Associated with Regimen Failure. Antimicrobial Agents and Chemotherapy. PMID 27001818 DOI: 10.1128/AAC.00038-16  0.96
2016 Tebit DM, Patel H, Ratcliffe A, Alessandri E, Liu J, Carpenter C, Plantier JC, Arts E. HIV-1 group O genotypes and phenotypes: relationship to fitness and susceptibility to antiretroviral drugs. Aids Research and Human Retroviruses. PMID 26861573 DOI: 10.1089/AID.2015.0318  0.96
2015 Nankya IL, Tebit DM, Abraha A, Kyeyune F, Gibson R, Jegede O, Nickel G, Arts EJ. Defining the fitness of HIV-1 isolates with dual/mixed co-receptor usage. Aids Research and Therapy. 12: 34. PMID 26435727 DOI: 10.1186/s12981-015-0066-7  0.96
2015 Bagaya BS, Vega JF, Tian M, Nickel GC, Li Y, Krebs KC, Arts EJ, Gao Y. Functional bottlenecks for generation of HIV-1 intersubtype Env recombinants. Retrovirology. 12: 44. PMID 25997955 DOI: 10.1186/s12977-015-0170-8  0.96
2015 Rausch JW, Tian M, Li Y, Angelova L, Bagaya BS, Krebs KC, Qian F, Zhu C, Arts EJ, Le Grice SF, Gao Y. SiRNA-induced mutation in HIV-1 polypurine tract region and its influence on viral fitness. Plos One. 10: e0122953. PMID 25860884 DOI: 10.1371/journal.pone.0122953  0.96
2014 Rubio AE, Abraha A, Carpenter CA, Troyer RM, Reyes-Rodríguez AL, Salomon H, Arts EJ, Tebit DM. Similar replicative fitness is shared by the subtype B and unique BF recombinant HIV-1 isolates that dominate the epidemic in Argentina Plos One. 9. PMID 24727861 DOI: 10.1371/journal.pone.0092084  0.96
2014 Liu Y, Rao U, McClure J, Konopa P, Manocheewa S, Kim M, Chen L, Troyer RM, Tebit DM, Holte S, Arts EJ, Mullins JI. Impact of mutations in highly conserved amino acids of the HIV-1 Gag-p24 and Env-gp120 proteins on viral replication in different genetic backgrounds. Plos One. 9: e94240. PMID 24713822 DOI: 10.1371/journal.pone.0094240  0.96
2013 Lemonovich TL, Watkins RR, Morrison CS, Kwok C, Chipato T, Musoke R, Arts EJ, Nankya I, Salata RA. Differences in Clinical Manifestations of Acute and Early HIV-1 Infection between HIV-1 Subtypes in African Women. Journal of the International Association of Providers of Aids Care. PMID 24106054 DOI: 10.1177/2325957413504827  0.96
2013 Kyeyune F, Nankya I, Metha S, Akao J, Ndashimye E, Tebit DM, Rodriguez B, Kityo C, Salata RA, Mugyenyi P, Arts EJ. Treatment failure and drug resistance is more frequent in HIV-1 subtype D versus subtype A-infected Ugandans over a 10-year study period Aids. 27: 1899-1909. PMID 23727942 DOI: 10.1097/QAD.0b013e3283610ec7  0.96
2013 Lobritz MA, Ratcliff AN, Marozsan AJ, Dudley DM, Tilton JC, Arts EJ. Multifaceted mechanisms of HIV inhibition and resistance to CCR5 inhibitors PSC-RANTES and Maraviroc. Antimicrobial Agents and Chemotherapy. 57: 2640-50. PMID 23529732 DOI: 10.1128/AAC.02511-12  0.96
2013 Weber J, Vazquez AC, Winner D, Gibson RM, Rhea AM, Rose JD, Wylie D, Henry K, Wright A, King K, Archer J, Poveda E, Soriano V, Robertson DL, Olivo PD, ... Arts EJ, et al. Sensitive cell-based assay for determination of human immunodeficiency virus type 1 coreceptor tropism. Journal of Clinical Microbiology. 51: 1517-27. PMID 23486708 DOI: 10.1128/JCM.00092-13  0.96
2013 Chamanian M, Purzycka KJ, Wille PT, Ha JS, McDonald D, Gao Y, Le Grice SF, Arts EJ. A cis-acting element in retroviral genomic RNA links Gag-Pol ribosomal frameshifting to selective viral RNA encapsidation. Cell Host & Microbe. 13: 181-92. PMID 23414758 DOI: 10.1016/j.chom.2013.01.007  0.96
2013 King DF, Siddiqui AA, Buffa V, Fischetti L, Gao Y, Stieh D, McKay PF, Rogers P, Ochsenbauer C, Kappes JC, Arts EJ, Shattock RJ. Mucosal tissue tropism and dissemination of HIV-1 subtype B acute envelope-expressing chimeric virus. Journal of Virology. 87: 890-9. PMID 23135721 DOI: 10.1128/JVI.02216-12  0.96
2013 Ratcliff AN, Shi W, Arts EJ. HIV-1 resistance to maraviroc conferred by a CD4 binding site mutation in the envelope glycoprotein gp120. Journal of Virology. 87: 923-34. PMID 23135713 DOI: 10.1128/JVI.01863-12  0.96
2013 Tebit DM, Arts EJ. From Simian to Human Immunodeficiency Viruses (SIV to HIV): Emergence from Nonhuman Primates and Transmission to Humans The Role of Animals in Emerging Viral Diseases. 201-234. DOI: 10.1016/B978-0-12-405191-1.00009-0  0.96
2012 Archer J, Weber J, Henry K, Winner D, Gibson R, Lee L, Paxinos E, Arts EJ, Robertson DL, Mimms L, Quiñones-Mateu ME. Use of four next-generation sequencing platforms to determine HIV-1 coreceptor tropism. Plos One. 7: e49602. PMID 23166726 DOI: 10.1371/journal.pone.0049602  0.96
2012 Arts EJ. Commentary on the role of treatment-related HIV compensatory mutations on increasing virulence: new discoveries twenty years since the clinical testing of protease inhibitors to block HIV-1 replication. Bmc Medicine. 10: 114. PMID 23031614 DOI: 10.1186/1741-7015-10-114  0.96
2012 Immonen T, Gibson R, Leitner T, Miller MA, Arts EJ, Somersalo E, Calvetti D. A hybrid stochastic-deterministic computational model accurately describes spatial dynamics and virus diffusion in HIV-1 growth competition assay. Journal of Theoretical Biology. 312: 120-32. PMID 22814476 DOI: 10.1016/j.jtbi.2012.07.005  0.96
2012 Arts EJ, Hazuda DJ. HIV-1 antiretroviral drug therapy. Cold Spring Harbor Perspectives in Medicine. 2: a007161. PMID 22474613 DOI: 10.1101/cshperspect.a007161  0.96
2012 Santos AF, Tebit DM, Lalonde MS, Abecasis AB, Ratcliff A, Camacho RJ, Diaz RS, Herchenröder O, Soares MA, Arts EJ. Effect of natural polymorphisms in the HIV-1 CRF02_AG protease on protease inhibitor hypersusceptibility. Antimicrobial Agents and Chemotherapy. 56: 2719-25. PMID 22330918 DOI: 10.1128/AAC.06079-11  0.96
2012 Gibson RM, Arts EJ. Past, present, and future of entry inhibitors as HIV microbicides. Current Hiv Research. 10: 19-26. PMID 22264042 DOI: 10.2174/157016212799304616  0.96
2011 Weber J, Vazquez AC, Winner D, Rose JD, Wylie D, Rhea AM, Henry K, Pappas J, Wright A, Mohamed N, Gibson R, Rodriguez B, Soriano V, King K, Arts EJ, et al. Novel method for simultaneous quantification of phenotypic resistance to maturation, protease, reverse transcriptase, and integrase HIV inhibitors based on 3'Gag(p2/p7/p1/p6)/PR/RT/INT-recombinant viruses: a useful tool in the multitarget era of antiretroviral therapy. Antimicrobial Agents and Chemotherapy. 55: 3729-42. PMID 21628544 DOI: 10.1128/AAC.00396-11  0.96
2011 Lalonde MS, Lobritz MA, Ratcliff A, Chamanian M, Athanassiou Z, Tyagi M, Wong J, Robinson JA, Karn J, Varani G, Arts EJ. Inhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the Tat-transactivating response element (TAR) RNA. Plos Pathogens. 7: e1002038. PMID 21625572 DOI: 10.1371/journal.ppat.1002038  0.96
2011 Lobritz MA, Lassen KG, Arts EJ. HIV-1 replicative fitness in elite controllers. Current Opinion in Hiv and Aids. 6: 214-20. PMID 21430530 DOI: 10.1097/COH.0b013e3283454cf5  0.96
2011 Gao Y, Abreha M, Nelson KN, Baird H, Dudley DM, Abraha A, Arts EJ. Enrichment of intersubtype HIV-1 recombinants in a dual infection system using HIV-1 strain-specific siRNAs. Retrovirology. 8: 5. PMID 21232148 DOI: 10.1186/1742-4690-8-5  0.96
2011 Tebit DM, Arts EJ. Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease. The Lancet. Infectious Diseases. 11: 45-56. PMID 21126914 DOI: 10.1016/S1473-3099(10)70186-9  0.96
2010 Lobritz MA, Ratcliff AN, Arts EJ. HIV-1 Entry, Inhibitors, and Resistance. Viruses. 2: 1069-105. PMID 21994672 DOI: 10.3390/v2051069  0.96
2010 Lalonde MS, Arts EJ. DNA suspension arrays: silencing discrete artifacts for high-sensitivity applications. Plos One. 5: e15476. PMID 21079742 DOI: 10.1371/journal.pone.0015476  0.96
2010 Tebit DM, Lobritz M, Lalonde M, Immonen T, Singh K, Sarafianos S, Herchenröder O, Kräusslich HG, Arts EJ. Divergent evolution in reverse transcriptase (RT) of HIV-1 group O and M lineages: impact on structure, fitness, and sensitivity to nonnucleoside RT inhibitors. Journal of Virology. 84: 9817-30. PMID 20631150 DOI: 10.1128/JVI.00991-10  0.96
2009 Soares EA, Santos AF, Gonzalez LM, Lalonde MS, Tebit DM, Tanuri A, Arts EJ, Soares MA. Mutation T74S in HIV-1 subtype B and C proteases resensitizes them to ritonavir and indinavir and confers fitness advantage. The Journal of Antimicrobial Chemotherapy. 64: 938-44. PMID 19710076 DOI: 10.1093/jac/dkp315  0.96
2009 Johnston SH, Lobritz MA, Nguyen S, Lassen K, Delair S, Posta F, Bryson YJ, Arts EJ, Chou T, Lee B. A quantitative affinity-profiling system that reveals distinct CD4/CCR5 usage patterns among human immunodeficiency virus type 1 and simian immunodeficiency virus strains. Journal of Virology. 83: 11016-26. PMID 19692480 DOI: 10.1128/JVI.01242-09  0.96
2009 Dudley DM, Gao Y, Nelson KN, Henry KR, Nankya I, Gibson RM, Arts EJ. A novel yeast-based recombination method to clone and propagate diverse HIV-1 isolates. Biotechniques. 46: 458-67. PMID 19480640 DOI: 10.2144/000113119  0.96
2009 Christie NM, Willer DO, Lobritz MA, Chan JK, Arts EJ, Ostrowski MA, Cochrane A, Luscher MA, MacDonald KS. Viral fitness implications of variation within an immunodominant CD8+ T-cell epitope of HIV-1 Virology. 388: 137-146. PMID 19368950 DOI: 10.1016/j.virol.2009.03.003  0.96
2009 Lassen KG, Lobritz MA, Bailey JR, Johnston S, Nguyen S, Lee B, Chou T, Siliciano RF, Markowitz M, Arts EJ. Elite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kinetics. Plos Pathogens. 5: e1000377. PMID 19360131 DOI: 10.1371/journal.ppat.1000377  0.96
2009 Troyer RM, McNevin J, Liu Y, Zhang SC, Krizan RW, Abraha A, Tebit DM, Zhao H, Avila S, Lobritz MA, McElrath MJ, Le Gall S, Mullins JI, Arts EJ. Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response. Plos Pathogens. 5: e1000365. PMID 19343217 DOI: 10.1371/journal.ppat.1000365  0.96
2009 Abraha A, Nankya IL, Gibson R, Demers K, Tebit DM, Johnston E, Katzenstein D, Siddiqui A, Herrera C, Fischetti L, Shattock RJ, Arts EJ. CCR5- and CXCR4-tropic subtype C human immunodeficiency virus type 1 isolates have a lower level of pathogenic fitness than other dominant group M subtypes: implications for the epidemic. Journal of Virology. 83: 5592-605. PMID 19297481 DOI: 10.1128/JVI.02051-08  0.96
2009 Bajunirwe F, Tisch DJ, King CH, Arts EJ, Debanne SM, Sethi AK. Quality of life and social support among patients receiving antiretroviral therapy in Western Uganda. Aids Care. 21: 271-9. PMID 19280404 DOI: 10.1080/09540120802241863  0.96
2009 Dudley DM, Wentzel JL, Lalonde MS, Veazey RS, Arts EJ. Selection of a simian-human immunodeficiency virus strain resistant to a vaginal microbicide in macaques. Journal of Virology. 83: 5067-76. PMID 19279098 DOI: 10.1128/JVI.00055-09  0.96
2009 Bajunirwe F, Arts EJ, Tisch DJ, King CH, Debanne SM, Sethi AK. Adherence and treatment response among HIV-1-infected adults receiving antiretroviral therapy in a rural government hospital in Southwestern Uganda. Journal of the International Association of Physicians in Aids Care (Chicago, Ill. : 2002). 8: 139-47. PMID 19258526 DOI: 10.1177/1545109709332470  0.96
2009 Miura T, Brockman MA, Schneidewind A, Lobritz M, Pereyra F, Rathod A, Block BL, Brumme ZL, Brumme CJ, Baker B, Rothchild AC, Li B, Trocha A, Cutrell E, Frahm N, ... ... Arts EJ, et al. HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition. Journal of Virology. 83: 2743-55. PMID 19116253 DOI: 10.1128/JVI.02265-08  0.96
2009 Gao Y, Nankya I, Abraha A, Troyer RM, Nelson KN, Rubio A, Arts EJ. Calculating HIV-1 infectious titre using a virtual TCID(50) method. Methods in Molecular Biology (Clifton, N.J.). 485: 27-35. PMID 19020816 DOI: 10.1007/978-1-59745-170-3_3  0.96
2009 Siddiqui AA, King DF, Buffa V, Fischetti L, Ochsenbauer-Jambor C, Gao Y, Krebs KC, Kappes JC, Arts EJ, Shattock RJ. P20-15. Evaluation of HIV-1 subtype B acute envelope-expressing infectious molecular clones Retrovirology. 6. DOI: 10.1186/1742-4690-6-S3-P385  0.96
2009 Rolland MM, Swain VJ, Lanxon-Cookson E, Rao U, Henry KR, Arts EJ, Nickle DC, Mullins JI. P17-14. Fitness-informed HIV-1 Gag-p24 vaccine design Retrovirology. 6. DOI: 10.1186/1742-4690-6-S3-P296  0.96
2009 Miura T, Brockman MA, Schneidewind A, Lobritz M, Pereyra F, Rathod A, Block BL, Brumme ZL, Brumme CJ, Baker B, Rothchild AC, Li B, Trocha A, Cutrell E, Frahm N, ... ... Arts EJ, et al. HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte recognition (Journal of Virology (2009) 83, 6, (2743-2755)) Journal of Virology. 83: 5961. DOI: 10.1128/JVI.00579-09  0.96
2008 Archer J, Pinney JW, Fan J, Simon-Loriere E, Arts EJ, Negroni M, Robertson DL. Identifying the important HIV-1 recombination breakpoints. Plos Computational Biology. 4: e1000178. PMID 18787691 DOI: 10.1371/journal.pcbi.1000178  0.96
2008 Troyer RM, Lalonde MS, Fraundorf E, Demers KR, Kyeyune F, Mugyenyi P, Syed A, Whalen CC, Bajunirwe F, Arts EJ. A radiolabeled oligonucleotide ligation assay demonstrates the high frequency of nevirapine resistance mutations in HIV type 1 quasispecies of NVP-treated and untreated mother-infant pairs from Uganda. Aids Research and Human Retroviruses. 24: 235-50. PMID 18284323 DOI: 10.1089/aid.2007.0138  0.96
2008 Gao Y, Lobritz MA, Roth J, Abreha M, Nelson KN, Nankya I, Moore-Dudley DM, Abraha A, Gerson SL, Arts EJ. Targets of small interfering RNA restriction during human immunodeficiency virus type 1 replication. Journal of Virology. 82: 2938-51. PMID 18199654 DOI: 10.1128/JVI.02126-07  0.96
2008 Ndembi N, Abraha A, Pilch H, Ichimura H, Mbanya D, Kaptue L, Salata R, Arts EJ. Molecular characterization of human immunodeficiency virus type 1 (HIV-1) and HIV-2 in Yaounde, Cameroon: evidence of major drug resistance mutations in newly diagnosed patients infected with subtypes other than subtype B. Journal of Clinical Microbiology. 46: 177-84. PMID 17855574 DOI: 10.1128/JCM.00428-07  0.96
2007 Weber J, Henry KR, Arts EJ, Quiñones-Mateu ME. Viral fitness: relation to drug resistance mutations and mechanisms involved: nucleoside reverse transcriptase inhibitor mutations. Current Opinion in Hiv and Aids. 2: 81-7. PMID 19372871 DOI: 10.1097/COH.0b013e328051b4e8  0.96
2007 Liu Y, McNevin J, Zhao H, Tebit DM, Troyer RM, McSweyn M, Ghosh AK, Shriner D, Arts EJ, McElrath MJ, Mullins JI. Evolution of human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitopes: fitness-balanced escape. Journal of Virology. 81: 12179-88. PMID 17728222 DOI: 10.1128/JVI.01277-07  0.96
2007 Tebit DM, Nankya I, Arts EJ, Gao Y. HIV diversity, recombination and disease progression: how does fitness "fit" into the puzzle? Aids Reviews. 9: 75-87. PMID 17694675  0.96
2007 Lalonde MS, Troyer RM, Syed AR, Bulime S, Demers K, Bajunirwe F, Arts EJ. Sensitive oligonucleotide ligation assay for low-level detection of nevirapine resistance mutations in human immunodeficiency virus type 1 quasispecies. Journal of Clinical Microbiology. 45: 2604-15. PMID 17567789 DOI: 10.1128/JCM.00431-07  0.96
2007 Anastassopoulou CG, Marozsan AJ, Matet A, Snyder AD, Arts EJ, Kuhmann SE, Moore JP. Escape of HIV-1 from a small molecule CCR5 inhibitor is not associated with a fitness loss. Plos Pathogens. 3: e79. PMID 17542646 DOI: 10.1371/journal.ppat.0030079  0.96
2007 Lobritz MA, Marozsan AJ, Troyer RM, Arts EJ. Natural variation in the V3 crown of human immunodeficiency virus type 1 affects replicative fitness and entry inhibitor sensitivity. Journal of Virology. 81: 8258-69. PMID 17522224 DOI: 10.1128/JVI.02739-06  0.96
2007 Henry KR, Weber J, Quiñones-Mateu ME, Arts EJ. The impact of viral and host elements on HIV fitness and disease progression. Current Hiv/Aids Reports. 4: 36-41. PMID 17338859 DOI: 10.1007/s11904-007-0006-9  0.96
2007 Ariën KK, Vanham G, Arts EJ. Is HIV-1 evolving to a less virulent form in humans? Nature Reviews. Microbiology. 5: 141-51. PMID 17203103 DOI: 10.1038/nrmicro1594  0.96
2006 Baird HA, Gao Y, Galetto R, Lalonde M, Anthony RM, Giacomoni V, Abreha M, Destefano JJ, Negroni M, Arts EJ. Influence of sequence identity and unique breakpoints on the frequency of intersubtype HIV-1 recombination. Retrovirology. 3: 91. PMID 17164002 DOI: 10.1186/1742-4690-3-91  0.96
2006 Baird HA, Galetto R, Gao Y, Simon-Loriere E, Abreha M, Archer J, Fan J, Robertson DL, Arts EJ, Negroni M. Sequence determinants of breakpoint location during HIV-1 intersubtype recombination. Nucleic Acids Research. 34: 5203-16. PMID 17003055 DOI: 10.1093/nar/gkl669  0.96
2006 Quiñones-Mateu ME, Arts EJ. Virus fitness: Concept, quantification, and application to HIV population dynamics Current Topics in Microbiology and Immunology. 299: 83-140. PMID 16568897  0.96
2005 Ariën KK, Troyer RM, Gali Y, Colebunders RL, Arts EJ, Vanham G. Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time. Aids (London, England). 19: 1555-64. PMID 16184024  0.96
2005 Moore DM, Arts EJ, Gao Y, Marozsan AJ. A yeast recombination-based cloning system to produce chimeric HIV-1 viruses and express HIV-1 genes. Methods in Molecular Biology (Clifton, N.J.). 304: 369-85. PMID 16061990 DOI: 10.1385/1-59259-907-9:369  0.96
2005 Abraha A, Troyer RM, Quiñones-Mateu ME, Arts EJ. Methods to determine HIV-1 ex vivo fitness. Methods in Molecular Biology (Clifton, N.J.). 304: 355-68. PMID 16061989 DOI: 10.1385/1-59259-907-9:355  0.96
2005 Troyer RM, Collins KR, Abraha A, Fraundorf E, Moore DM, Krizan RW, Toossi Z, Colebunders RL, Jensen MA, Mullins JI, Vanham G, Arts EJ. Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progression. Journal of Virology. 79: 9006-18. PMID 15994794 DOI: 10.1128/JVI.79.14.9006-9018.2005  0.96
2005 Ariën KK, Abraha A, Quiñones-Mateu ME, Kestens L, Vanham G, Arts EJ. The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates. Journal of Virology. 79: 8979-90. PMID 15994792 DOI: 10.1128/JVI.79.14.8979-8990.2005  0.96
2005 Marozsan AJ, Moore DM, Lobritz MA, Fraundorf E, Abraha A, Reeves JD, Arts EJ. Differences in the fitness of two diverse wild-type human immunodeficiency virus type 1 isolates are related to the efficiency of cell binding and entry. Journal of Virology. 79: 7121-34. PMID 15890952 DOI: 10.1128/JVI.79.11.7121-7134.2005  0.96
2005 Baird HA, Marozsan AJ, Lederman MM, Landay A, Mildvan D, Kuritzkes DR, Kessler HA, Arts EJ. Monitoring processed, mature Human Immunodeficiency Virus type 1 particles immediately following treatment with a protease inhibitor-containing treatment regimen. Aids Research and Therapy. 2: 2. PMID 15826302 DOI: 10.1186/1742-6405-2-2  0.96
2004 Bajunirwe F, Massaquoi I, Asiimwe S, Kamya MR, Arts EJ, Whalen CC. Effectiveness of nevirapine and zidovudine in a pilot program for the prevention of mother-to-child transmission of HIV-1 in Uganda. African Health Sciences. 4: 146-54. PMID 15687066  0.96
2004 Marozsan AJ, Fraundorf E, Abraha A, Baird H, Moore D, Troyer R, Nankja I, Arts EJ. Relationships between infectious titer, capsid protein levels, and reverse transcriptase activities of diverse human immunodeficiency virus type 1 isolates. Journal of Virology. 78: 11130-41. PMID 15452233 DOI: 10.1128/JVI.78.20.11130-11141.2004  0.96
2004 Kawamura T, Bruse SE, Abraha A, Sugaya M, Hartley O, Offord RE, Arts EJ, Zimmerman PA, Blauvelt A, Bruce SE. PSC-RANTES blocks R5 human immunodeficiency virus infection of Langerhans cells isolated from individuals with a variety of CCR5 diplotypes. Journal of Virology. 78: 7602-9. PMID 15220435 DOI: 10.1128/JVI.78.14.7602-7609.2004  0.96
2004 Richard N, Juntilla M, Abraha A, Demers K, Paxinos E, Galovich J, Petropoulos C, Whalen CC, Kyeyune F, Atwine D, Kityo C, Mugyenyi P, Arts EJ. High prevalence of antiretroviral resistance in treated Ugandans infected with non-subtype B human immunodeficiency virus type 1. Aids Research and Human Retroviruses. 20: 355-64. PMID 15157354 DOI: 10.1089/088922204323048104  0.96
2004 Gao Y, Paxinos E, Galovich J, Troyer R, Baird H, Abreha M, Kityo C, Mugyenyi P, Petropoulos C, Arts EJ. Characterization of a subtype D human immunodeficiency virus type 1 isolate that was obtained from an untreated individual and that is highly resistant to nonnucleoside reverse transcriptase inhibitors. Journal of Virology. 78: 5390-401. PMID 15113918 DOI: 10.1128/JVI.78.10.5390-5401.2004  0.96
2003 Marozsan AJ, Arts EJ. Development of a yeast-based recombination cloning/system for the analysis of gene products from diverse human immunodeficiency virus type 1 isolates. Journal of Virological Methods. 111: 111-20. PMID 12880926 DOI: 10.1016/S0166-0934(03)00166-6  0.96
2003 Arts EJ, Quiñones-Mateu ME. Sorting out the complexities of HIV-1 fitness. Aids (London, England). 17: 780-1. PMID 12646811 DOI: 10.1097/01.aids.0000050881.72891.32  0.96
2003 Ball SC, Abraha A, Collins KR, Marozsan AJ, Baird H, Quiñones-Mateu ME, Penn-Nicholson A, Murray M, Richard N, Lobritz M, Zimmerman PA, Kawamura T, Blauvelt A, Arts EJ. Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C. Journal of Virology. 77: 1021-38. PMID 12502818 DOI: 10.1128/JVI.77.2.1021-1038.2003  0.96
2002 Quiñones-Mateu ME, Arts EJ. Fitness of drug resistant HIV-1: methodology and clinical implications. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 5: 224-33. PMID 12531179 DOI: 10.1016/S1368-7646(02)00123-1  0.96
2002 Collins KR, Quiñones-Mateu ME, Toossi Z, Arts EJ. Impact of tuberculosis on HIV-1 replication, diversity, and disease progression. Aids Reviews. 4: 165-76. PMID 12416451  0.96
2002 Quiñones-Mateu ME, Gao Y, Ball SC, Marozsan AJ, Abraha A, Arts EJ. In vitro intersubtype recombinants of human immunodeficiency virus type 1: comparison to recent and circulating in vivo recombinant forms. Journal of Virology. 76: 9600-13. PMID 12208939 DOI: 10.1128/JVI.76.19.9600-9613.2002  0.96
2002 Collins KR, Quiñones-Mateu ME, Wu M, Luzze H, Johnson JL, Hirsch C, Toossi Z, Arts EJ. Human immunodeficiency virus type 1 (HIV-1) quasispecies at the sites of Mycobacterium tuberculosis infection contribute to systemic HIV-1 heterogeneity. Journal of Virology. 76: 1697-706. PMID 11799165 DOI: 10.1128/JVI.76.4.1697-1706.2002  0.96
2001 Marozsan AJ, Torre VS, Johnson M, Ball SC, Cross JV, Templeton DJ, Quiñones-Mateu ME, Offord RE, Arts EJ. Mechanisms involved in stimulation of human immunodeficiency virus type 1 replication by aminooxypentane RANTES. Journal of Virology. 75: 8624-38. PMID 11507208 DOI: 10.1128/JVI.75.18.8624-8638.2001  0.96
2001 Menéndez-Arias L, Abraha A, Quiñones-Mateu ME, Mas A, Camarasa MJ, Arts EJ. Functional Characterization of Chimeric Reverse Transcriptases with Polypeptide Subunits of Highly Divergent HIV-1 Group M and O Strains Journal of Biological Chemistry. 276: 27470-27479. PMID 11353775 DOI: 10.1074/jbc.M104342200  0.96
2000 Collins KR, Mayanja-Kizza H, Sullivan BA, Quiñones-Mateu ME, Toossi Z, Arts EJ. Greater diversity of HIV-1 quasispecies in HIV-infected individuals with active tuberculosis Journal of Acquired Immune Deficiency Syndromes. 24: 408-417. PMID 11035611  0.96
2000 Quiñones-Mateu ME, Ball SC, Marozsan AJ, Torre VS, Albright JL, Vanham G, van Der Groen G, Colebunders RL, Arts EJ. A dual infection/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression. Journal of Virology. 74: 9222-33. PMID 10982369 DOI: 10.1128/JVI.74.19.9222-9233.2000  0.96
2000 Torre VS, Marozsan AJ, Albright JL, Collins KR, Hartley O, Offord RE, Quiñones-Mateu ME, Arts EJ. Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs. Journal of Virology. 74: 4868-76. PMID 10775626 DOI: 10.1128/JVI.74.10.4868-4876.2000  0.96
2000 García Lerma JG, Soriano V, Mas A, Quiñones-Mateu ME, Arts EJ, Heneine W. Quantitation of human immunodeficiency virus type 1 group O load in plasma by measuring reverse transcriptase activity Journal of Clinical Microbiology. 38: 402-405. PMID 10618125  0.96
2000 Quiñones-Mateu ME, Ball SC, Arts EJ. Role of human immunodeficiency virus type 1 group O in the AIDS pandemic Aids Reviews. 2: 190-202.  0.96
1999 Quiñones-Mateu ME, Albright JL, Torre V, Reinis M, Vandasová J, Brucková M, Arts EJ. Molecular epidemiology of HIV type 1 isolates from the Czech Republic: identification of an env E subtype case. Aids Research and Human Retroviruses. 15: 85-9. PMID 10024058 DOI: 10.1089/088922299311763  0.96
1998 Quiñones-Mateu ME, Albright JL, Mas A, Soriano V, Arts EJ. Analysis of pol gene heterogeneity, viral quasispecies, and drug resistance in individuals infected with group O strains of human immunodeficiency virus type 1 Journal of Virology. 72: 9002-9015. PMID 9765445  0.96
1998 Arts EJ, Miller JT, Ehresmann B, Le Grice SFJ. Mutating a region of HIV-1 reverse transcriptase implicated in tRNA(Lys- 3) binding and the consequences for (-)-strand DNA synthesis Journal of Biological Chemistry. 273: 14523-14532. PMID 9603966 DOI: 10.1074/jbc.273.23.14523  0.96
1998 Arts EJ, Quiñones-Mateu ME, Albright JL, Marois JP, Hough C, Gu Z, Wainberg MA. 3'-Azido-3'-deoxythymidine (AZT) mediates cross-resistance to nucleoside analogs in the case of AZT-resistant human immunodeficiency virus type 1 variants. Journal of Virology. 72: 4858-65. PMID 9573252  0.96
1998 Arts EJ, Le Grice SF. Interaction of retroviral reverse transcriptase with template-primer duplexes during replication Progress in Nucleic Acid Research and Molecular Biology. 58: 339-393. PMID 9308371  0.96
1998 Arts EJ, Quiñones-Mateu ME, Albright JL. Mechanisms of clinical resistance by HIV-I variants to zidovudine and the paradox of reverse transcriptase sensitivity Drug Resistance Updates. 1: 21-28. DOI: 10.1016/S1368-7646(98)80211-2  0.96
1996 Arts EJ, Wainberg MA. Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription Antimicrobial Agents and Chemotherapy. 40: 527-540. PMID 8851566  0.96
1996 Arts EJ, Wainberg MA. Human immunodeficiency virus type 1 reverse transcriptase and early events in reverse transcription Advances in Virus Research. 46: 97-163. PMID 8824699  0.96
1996 Arts EJ, Stetor SR, Li X, Rausch JW, Howard KJ, Ehresmann B, North TW, Wöhrl BM, Goody RS, Wainberg MA, Le Grice SFJ. Initiation of (-) strand DNA synthesis from tRNALys3 on lentiviral RNAs: Implications of specific HIV-1 RNA-tRNALys3 interactions inhibiting primer utilization by retroviral reverse transcriptases Proceedings of the National Academy of Sciences of the United States of America. 93: 10063-10068. PMID 8816751  0.96
1996 Li X, Quan Y, Arts EJ, Li Z, Preston BD, De Rocquigny H, Roques BP, Darlix JL, Kleiman L, Parniak MA, Wainberg MA. Human immunodeficiency virus type 1 nucleocapsid protein (NCp7) directs specific initiation of minus-strand DNA synthesis primed by human tRNA3/(Lys) in vitro: Studies of viral RNA molecules mutated in regions that flank the primer binding site Journal of Virology. 70: 4996-5004. PMID 8764006  0.96
1996 Rausch JW, Arts EJ, Wöhrl BM, Le Grice SFJ. Involvement of C-terminal structural elements of equine infectious anemia virus reverse transcriptase in DNA polymerase and ribonuclease H activities Journal of Molecular Biology. 257: 500-511. PMID 8648620 DOI: 10.1006/jmbi.1996.0181  0.96
1996 Arts EJ, Ghosh M, Jacques PS, Ehresmann B, Le Grice SFJ. Restoration of tRNA3Lys-primed (-)-strand DNA synthesis to an HIV-1 reverse transcriptase mutant with extended tRNAs Implications for retroviral replication Journal of Biological Chemistry. 271: 9054-9061. PMID 8621554 DOI: 10.1074/jbc.271.15.9054  0.96
1996 Arts EJ, Marois JP, Zhengxian GU, Le Grice SFJ, Wainberg MA. Effects of 3′-deoxynucleoside 5′-triphosphate concentrations on chain termination by nucleoside analogs during human immunodeficiency virus type 1 reverse transcription of minus-strand strong-stop DNA Journal of Virology. 70: 712-720. PMID 8551607  0.96
1995 Gu Z, Quan Y, Li Z, Arts EJ, Wainberg MA. Effects of non-nucleoside inhibitors of human immunodeficiency virus type 1 in cell-free recombinant reverse transcriptase assays Journal of Biological Chemistry. 270: 31046-31051. PMID 8537362 DOI: 10.1074/jbc.270.52.31046  0.96
1995 Wainberg MA, Gu Z, Salomon H, Arts EJ, Kleiman L, Parniak MA, Morin N. Molecular basis and clinical significance of HIV-1 resistance to nucleoside compounds Comptes Rendus De L"Academie Des Sciences. Serie Iii, Sciences De La Vie. 318: 315-328. PMID 7540494  0.96
1995 Gu Z, Arts EJ, Parniak MA, Wainberg MA. Mutated K65R recombinant reverse transcriptase of human immunodeficiency virus type 1 shows diminished chain termination in the presence of 2′,3′-dideoxycytidine 5′-triphosphate and other drugs Proceedings of the National Academy of Sciences of the United States of America. 92: 2760-2764. PMID 7535930 DOI: 10.1073/pnas.92.7.2760  0.96
1995 Arts EJ, Li Z, Wainberg MA. Analysis of primer extension and the first template switch during human immunodeficiency virus reverse transcription Journal of Biomedical Science. 2: 314-321. DOI: 10.1007/BF02255218  0.96
1994 Arts EJ, Wainberg MA. Preferential incorporation of nucleoside analogs after template switching during human immunodeficiency virus reverse transcription Antimicrobial Agents and Chemotherapy. 38: 1008-1016. PMID 7915097  0.96
1994 Gu Z, Fletcher RS, Arts EJ, Wainberg MA, Parniak MA. The K65R mutant reverse transcriptase of HIV-1 cross-resistant to 2′,3′-dideoxycytidine, 2′,3′-dideoxy-3′-thiacytidine, and 2′,3′-dideoxyinosine shows reduced sensitivity to specific dideoxynucleoside triphosphate inhibitors in vitro Journal of Biological Chemistry. 269: 28118-28122. PMID 7525567  0.96
1994 Li X, Mak J, Arts EJ, Gu Z, Kleiman L, Wainberg MA, Parniak MA. Effects of alterations of primer-binding site sequences on human immunodeficiency virus type 1 replication Journal of Virology. 68: 6198-6206. PMID 7521916  0.96
1994 Arts EJ, Mak J, Kleiman L, Wainberg MA. DNA found in human immunodeficiency virus type 1 particles may not be required for infectivity Journal of General Virology. 75: 1605-1613. PMID 7517431 DOI: 10.1099/0022-1317-75-7-1605  0.96
1994 Arts EJ, Li X, Gu Z, Kleiman L, Parniak MA, Wainberg MA. Comparison of deoxyoligonucleotide and tRNA(Lys-3) as primers in an endogenous human immunodeficiency virus-1 in vitro reverse transcription/template-switching reaction Journal of Biological Chemistry. 269: 14672-14680. PMID 7514178  0.96
1994 Arts EJ, Mak J, Kleiman L, Wainberg MA. Mature reverse transcriptase (p66/p51) is responsible for low levels of viral DNA found in human immunodeficiency virus type 1 (HIV-1) Leukemia. 8. PMID 7512179  0.96
1993 Geleziunas R, Arts EJ, Boulerice F, Goldman H, Wainberg MA. Effect of 3'-azido-3'-deoxythymidine on human immunodeficiency virus type 1 replication in human fetal brain macrophages Antimicrobial Agents and Chemotherapy. 37: 1305-1312. PMID 8392310 DOI: 10.1128/AAC.37.6.1305  0.96
Show low-probability matches.